The suit alleges the Seattle-based biotech misled investors regarding its funds and the effectiveness of some of its ...

NEW YORK, NY / ACCESS Newswire / April 7, 2025 / If you suffered a loss on your Sana Biotechnology, Inc. (NASDAQ:SANA) investment and want to ...

Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $40.1 billion by 2034, ...

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...

Sana Biotechnology, Inc.’s SANA share price has dipped by 11.16%, which has investors questioning if this is right time to buy.

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA). Shareholders who purchased shares of SANA ...

To join the Sana class action, go to https://rosenlegal.com/submit-form/?case_id=37267 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class ...

LOS ANGELES, April 7, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sana Biotechnology, Inc. ("Sana ...

NEW YORK, April 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA). Shareholders who purchased shares of SANA during ...

The suit alleges the Seattle-based biotech misled investors regarding its funds and the effectiveness of some of its treatment candidates. Seattle-based Sana Biotechnology Inc. (Nasdaq ...